We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
CALL
Halliburton
HAL
$27.9B
| $9K | 0.01% |
+3,000
| New | +$149K |
|
327
Antero Resources
AR
$11B
| $8K | 0.01% |
371
-511
| -58% | -$10K |
|
328
CALL
Goodyear
GT
$2.07B
| $8K | 0.01% |
20,000
+10,000
| +100% | +$257K |
|
329
Liberty Broadband Class A
LBRDA
$4.04B
| $8K | 0.01% |
107
-949
| -90% | -$71.5K |
|
330
Marriott International
MAR
$98.4B
| $8K | 0.01% |
+64
| New | +$8.7K |
|
331
Biogen
BIIB
$29.9B
| $6K | 0.01% |
+22
| New | +$6.18K |
|
|
CERN
332
DELISTED
Cerner Corp
CERN
| $5K | 0.01% |
79
-3,363
| -98% | -$199K |
|
333
Oshkosh
OSK
$9.68B
| $4K | 0.01% |
+53
| New | +$3.96K |
|
334
Thor Industries
THO
$4B
| $4K | 0.01% |
+46
| New | +$4.69K |
|
335
Autodesk
ADSK
$45B
| $3K | ﹤0.01% |
+26
| New | +$3.44K |
|
336
Fortune Brands Innovations
FBIN
$6.12B
| $3K | ﹤0.01% |
+59
| New | +$2.86K |
|
337
Fluor
FLR
$7.41B
| $3K | ﹤0.01% |
+57
| New | +$2.98K |
|
338
Sempra
SRE
$60.9B
| $3K | ﹤0.01% |
60
-596
| -91% | -$32.6K |
|
339
A.O. Smith
AOS
$8.39B
| $2K | ﹤0.01% |
37
-3,173
| -99% | -$200K |
|
340
Euronet Worldwide
EEFT
$2.99B
| $2K | ﹤0.01% |
+18
| New | +$1.46K |
|
341
ServiceNow
NOW
$101B
| $2K | ﹤0.01% |
+60
| New | +$2.08K |
|
342
Apple
AAPL
$4.9T
| $1K | ﹤0.01% |
12
-5,528
| -100% | -$251K |
|
343
AMC Global Media
AMCX
$438M
| $1K | ﹤0.01% |
+10
| New | +$571 |
|
344
Dollar Tree
DLTR
$23.2B
| $1K | ﹤0.01% |
6
-438
| -99% | -$40.4K |
|
345
Global Payments
GPN
$22B
| $1K | ﹤0.01% |
7
-1,925
| -100% | -$217K |
|
346
Hilton Grand Vacations
HGV
$3.86B
| $1K | ﹤0.01% |
23
-504
| -96% | -$20.4K |
|
347
MGM Resorts International
MGM
$11.7B
| $1K | ﹤0.01% |
+40
| New | +$1.29K |
|
348
Marathon Petroleum
MPC
$90.7B
| $1K | ﹤0.01% |
+18
| New | +$1.38K |
|
349
Nike
NKE
$62B
| $1K | ﹤0.01% |
+14
| New | +$986 |
|
350
Southern Copper
SCCO
$143B
| $1K | ﹤0.01% |
19
-636
| -97% | -$30.5K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.